NKF PSA - "20 Million People Have Chronic Kidney Disease"
Diaby V, Almutairi RD, Babcock A, Moussa RK, Ali A
Expert review of pharmacoeconomics & outcomes research
Diaby V, Almutairi RD, Babcock A, Moussa RK, Ali A. Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews. Expert Rev Pharmacoecon Outcomes Res. 2021 Jun; 21(3):353-364.
Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews.
CoPPS, IPH Health Policy and Administration
Hugh Roy and Lillie Cranz Cullen Distinguished University Professor of Clinical Psychology
PhD, Director of the Morphology Core and Technologies and Resources
Associate Director for Research Education
College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
Economic, Social, and Administrative Pharmacy
Adjei K, Adunlin G, Ali AA. Impact of Sertraline, Fluoxetine, and Escitalopram on Psychological Distress among United States Adult Outpatients with a Major Depressive Disorder. Healthcare (Basel). 2023 Mar 03; 11(5).
Impact of Sertraline, Fluoxetine, and Escitalopram on Psychological Distress among United States Adult Outpatients with a Major Depressive Disorder.
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Matyori A, Brown CP, Ali A, Sherbeny F. Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines. Saudi Pharm J. 2023 Jun; 31(6):795-800.
Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines.
Abegaz TM, Ahmed M, Ali AA, Bhagavathula AS
Abegaz TM, Ahmed M, Ali AA, Bhagavathula AS. Predicting Health-Related Quality of Life Using Social Determinants of Health: A Machine Learning Approach with the All of Us Cohort. Bioengineering (Basel). 2025 Feb 09; 12(2).
Predicting Health-Related Quality of Life Using Social Determinants of Health: A Machine Learning Approach with the All of Us Cohort.
Abegaz TM, Ali AA. Health-Related Quality of Life and Healthcare Events in Patients with Monotherapy of Anti-Diabetes Medications. Healthcare (Basel). 2023 Feb 12; 11(4).
Health-Related Quality of Life and Healthcare Events in Patients with Monotherapy of Anti-Diabetes Medications.
Luque JS, Kiros GE, Vargas MA, Ali A, Tawk R, Jackson DR, Dickey SL, Harris CM, Robinson T, Duncan B, Freeman J, Gwede CK, Wallace K
Luque JS, Kiros GE, Vargas MA, Ali A, Tawk R, Jackson DR, Dickey SL, Harris CM, Robinson T, Duncan B, Freeman J, Gwede CK, Wallace K. Effectiveness of a community health advisor colorectal cancer screening educational intervention on stool test completion in an African American primary care patient population: a pragmatic randomized controlled trial. BMC Glob Public Health. 2025 Jun 01; 3(1):47.
Effectiveness of a community health advisor colorectal cancer screening educational intervention on stool test completion in an African American primary care patient population: a pragmatic randomized controlled trial.
Abegaz TM, Baljoon A, Kilanko O, Sherbeny F, Ali AA
Abegaz TM, Baljoon A, Kilanko O, Sherbeny F, Ali AA. Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes. Comput Biol Med. 2023 09; 164:107289.
Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes.
Zhang X, Dutton M, Liu R, Ali AA, Sherbeny F
Zhang X, Dutton M, Liu R, Ali AA, Sherbeny F. Deep Learning-Based Survival Analysis for Receiving a Steatotic Donor Liver Versus Waiting for a Standard Liver. Transplant Proc. 2023 Dec; 55(10):2436-2443.
Deep Learning-Based Survival Analysis for Receiving a Steatotic Donor Liver Versus Waiting for a Standard Liver.
Adunlin G, Skiera J, Cupp CS, Ali AA, Afeli SAY
Adunlin G, Skiera J, Cupp CS, Ali AA, Afeli SAY. The State of Pharmacoeconomics Education in the Doctor of Pharmacy Curriculum amid the Changing Face of Pharmacy Practice. Healthcare (Basel). 2023 Nov 08; 11(22).
The State of Pharmacoeconomics Education in the Doctor of Pharmacy Curriculum amid the Changing Face of Pharmacy Practice.
Dong J, Reeves L, Ali A, Freeman MK, Adunlin G
Dong J, Reeves L, Ali A, Freeman MK, Adunlin G. A Systematic Review of the Effectiveness of Text Message Reminders on Asthma Medication Adherence. Innov Pharm. 2018; 9(3):1-7.
A Systematic Review of the Effectiveness of Text Message Reminders on Asthma Medication Adherence.
Nkemdirim Okere A, Li T, Theran C, Nyasani E, Ali AA
Nkemdirim Okere A, Li T, Theran C, Nyasani E, Ali AA. Evaluation of factors predicting transition from prediabetes to diabetes among patients residing in underserved communities in the United States - A machine learning approach. Comput Biol Med. 2025 Mar; 187:109824.
Evaluation of factors predicting transition from prediabetes to diabetes among patients residing in underserved communities in the United States - A machine learning approach.
Luque JS, Vargas M, Wallace K, Matthew OO, Tawk R, Ali AA, Kiros GE, Harris CM, Gwede CK
Journal of cancer education : the official journal of the American Association for Cancer Education
Luque JS, Vargas M, Wallace K, Matthew OO, Tawk R, Ali AA, Kiros GE, Harris CM, Gwede CK. Engaging the Community on Colorectal Cancer Screening Education: Focus Group Discussions Among African Americans. J Cancer Educ. 2022 04; 37(2):251-262.
Engaging the Community on Colorectal Cancer Screening Education: Focus Group Discussions Among African Americans.
Diaby V, Ali A, Babcock A, Fuhr J, Braithwaite D
Journal of managed care & specialty pharmacy
Diaby V, Ali A, Babcock A, Fuhr J, Braithwaite D. Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions. J Manag Care Spec Pharm. 2021 Sep; 27(9-a Suppl):S22-S29.
Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions.
Xiao H, Tan F, Goovaerts P, Adunlin G, Ali AA, Gwede CK, Huang Y
Xiao H, Tan F, Goovaerts P, Adunlin G, Ali AA, Gwede CK, Huang Y. Use of treatment information from a state central cancer registry in prostate cancer research. J Registry Manag. 2013; 40(3):127-30.
Use of treatment information from a state central cancer registry in prostate cancer research.
Xiao H, Tan F, Goovaerts P, Adunlin G, Ali A, Huang Y, Gwede CK
Journal of health care for the poor and underserved
Xiao H, Tan F, Goovaerts P, Adunlin G, Ali A, Huang Y, Gwede CK. Factors associated with time-to-treatment of prostate cancer in Florida. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):132-46.
Factors associated with time-to-treatment of prostate cancer in Florida.
Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Huang Y, Gwede C
Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Huang Y, Gwede C. Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data. J Registry Manag. 2013; 40(4):159-64.
Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data.
Ali AA, Xiao H, Kiros GE. Health insurance and breast-conserving surgery with radiation treatment. Am J Manag Care. 2014 Jun; 20(6):502-16.
Health insurance and breast-conserving surgery with radiation treatment.
Xiao H, Tan F, Adunlin G, Ali AA, Goovaerts P, Gwede CK, Huang Y
Xiao H, Tan F, Adunlin G, Ali AA, Goovaerts P, Gwede CK, Huang Y. Factors associated with overall survival prostate cancer in Florida: a multilevel analysis. J Health Care Poor Underserved. 2015 Feb; 26(1):266-77.
Factors associated with overall survival prostate cancer in Florida: a multilevel analysis.
Goovaerts P, Xiao H, Adunlin G, Ali A, Tan F, Gwede CK, Huang Y
Goovaerts P, Xiao H, Adunlin G, Ali A, Tan F, Gwede CK, Huang Y. GEOGRAPHICALLY-WEIGHTED REGRESSION ANALYSIS OF PERCENTAGE OF LATE-STAGE PROSTATE CANCER DIAGNOSIS IN FLORIDA. Appl Geogr. 2015 Aug 01; 62:191-200.
GEOGRAPHICALLY-WEIGHTED REGRESSION ANALYSIS OF PERCENTAGE OF LATE-STAGE PROSTATE CANCER DIAGNOSIS IN FLORIDA.
Goovaerts P, Xiao H, Gwede CK, Tan F, Huang Y, Adunlin G, Ali A
Goovaerts P, Xiao H, Gwede CK, Tan F, Huang Y, Adunlin G, Ali A. Impact of Age, Race and Socio-economic Status on Temporal Trends in Late-Stage Prostate Cancer Diagnosis in Florida. Spat Stat. 2015 Nov 01; 14(Pt 100):321-337.
Impact of Age, Race and Socio-economic Status on Temporal Trends in Late-Stage Prostate Cancer Diagnosis in Florida.
Queeley GL, Campbell ES, Ali AA. Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States. Am Health Drug Benefits. 2018 Jul; 11(5):223-230.
Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States.
Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Gwede CK, Huang Y
Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Gwede CK, Huang Y. Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida. Am J Mens Health. 2014 Jul; 8(4):316-26.
Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.
Diaby V, Adunlin G, Ali AA, Tawk R. Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial. Breast Cancer Res Treat. 2014 Aug; 146(3):669-73.
Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial.
Xiao H, Tan F, Goovaerts P, Adunlin G, Ali AA, Gwede CK, Huang Y. Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida. Am J Mens Health. 2016 07; 10(4):285-95.
Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.
Ali AA, Xiao H, Tawk R, Campbell E, Semykina A, Montero AJ, Diaby V
Ali AA, Xiao H, Tawk R, Campbell E, Semykina A, Montero AJ, Diaby V. Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy. Curr Med Res Opin. 2017 02; 33(2):391-400.
Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy.
Diaby V, Ali AA, Adunlin G, Kohn CG, Montero AJ
Diaby V, Ali AA, Adunlin G, Kohn CG, Montero AJ. Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients. Curr Med Res Opin. 2016 06; 32(6):991-6.
Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients.
Diaby V, Adunlin G, Ali AA, Zeichner SB, de Lima Lopes G, Kohn CG, Montero AJ
Diaby V, Adunlin G, Ali AA, Zeichner SB, de Lima Lopes G, Kohn CG, Montero AJ. Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Res Treat. 2016 11; 160(1):187-196.
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States.
Ali AA, Tawk R, Xiao H, Campbell E, Semykina A, Montero AJ, Mogos M, Diaby V
Ali AA, Tawk R, Xiao H, Campbell E, Semykina A, Montero AJ, Mogos M, Diaby V. Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data. Cancer Med. 2019 01; 8(1):117-127.
Comparative effectiveness of radiotherapy for early-stage hormone receptor-positive breast cancer in elderly women using real-world data.
Diaby V, Ali AA, Williams KJ, Ezendu K, Soto-Perez-de-Celis E, Chavarri-Guerra Y, de Lima Lopes G
Diaby V, Ali AA, Williams KJ, Ezendu K, Soto-Perez-de-Celis E, Chavarri-Guerra Y, de Lima Lopes G. Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives. Breast Cancer Res Treat. 2017 Dec; 166(3):951-963.
Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives.
Diaby V, Ali AA, Montero AJ. Value Assessment Frameworks in the United States: A Call for Patient Engagement. Pharmacoecon Open. 2019 Mar; 3(1):1-3.
Value Assessment Frameworks in the United States: A Call for Patient Engagement.
Xiao H, Jiang X, Chen C, Wang W, Wang CY, Ali AA, Berthe A, Moussa RK, Diaby V
Research in social & administrative pharmacy : RSAP
Xiao H, Jiang X, Chen C, Wang W, Wang CY, Ali AA, Berthe A, Moussa RK, Diaby V. Using time series analysis to forecast the health-related quality of life of post-menopausal women with non-metastatic ER+ breast cancer: A tutorial and case study. Res Social Adm Pharm. 2020 Aug; 16(8):1095-1099.
Using time series analysis to forecast the health-related quality of life of post-menopausal women with non-metastatic ER+ breast cancer: A tutorial and case study.
Diaby V, Alqhtani H, van Boemmel-Wegmann S, Wang CY, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G
Diaby V, Alqhtani H, van Boemmel-Wegmann S, Wang CY, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan. Breast. 2020 Feb; 49:141-148.
A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan.
Diaby V, Wang CY, Alqhtani H, van Boemmel-Wegmann S, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G
Diaby V, Wang CY, Alqhtani H, van Boemmel-Wegmann S, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting. Data Brief. 2020 Apr; 29:105194.
Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting.
Babcock A, Ali AA, Balkrishnan R, Montero A, Diaby V
Babcock A, Ali AA, Balkrishnan R, Montero A, Diaby V. Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary. J Manag Care Spec Pharm. 2020 Jul; 26(7):826-831.
Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary.
Ali AA, Tawk R, Xiao H, Semykina A, Montero AJ, Moussa RK, Popoola O, Diaby V
Ali AA, Tawk R, Xiao H, Semykina A, Montero AJ, Moussa RK, Popoola O, Diaby V. Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer. Expert Rev Pharmacoecon Outcomes Res. 2022 Jul; 22(5):735-741.
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer.
Luque JS, Matthew OO, Jackson DR, Vargas MA, Austin T, Ali A, Kiros GE, Harris CM, Tawk R, Gwede CK, Wallace K, Jean-Pierre P
Luque JS, Matthew OO, Jackson DR, Vargas MA, Austin T, Ali A, Kiros GE, Harris CM, Tawk R, Gwede CK, Wallace K, Jean-Pierre P. Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial. Trials. 2022 Feb 15; 23(1):151.
Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial.
Abegaz TM, Diaby V, Sherbeny F, Ali AA. Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA. Clin Drug Investig. 2022 Jun; 42(6):501-511.
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA.
Alotaibi A, Ali A, Brown C, Sherbeny F. Exploratory Analysis of Survival and Mortality Rates among Older Lung Cancer Patients Utilizing Different Treatment Modalities. Innov Pharm. 2022; 13(2).
Exploratory Analysis of Survival and Mortality Rates among Older Lung Cancer Patients Utilizing Different Treatment Modalities.
Luque JS, Kiros GE, Vargas M, Jackson DR, Matthew OO, Austin TD, Tawk R, Ali AA, Harris CM, Wallace K, Gwede CK
Luque JS, Kiros GE, Vargas M, Jackson DR, Matthew OO, Austin TD, Tawk R, Ali AA, Harris CM, Wallace K, Gwede CK. Association of Preventive Care Attitudes and Beliefs with Colorectal Cancer Screening History among African American Patients of Community Health Centers. J Cancer Educ. 2023 12; 38(6):1816-1824.
Association of Preventive Care Attitudes and Beliefs with Colorectal Cancer Screening History among African American Patients of Community Health Centers.
Abegaz TM, Ahmed M, Sherbeny F, Diaby V, Chi H, Ali AA
Abegaz TM, Ahmed M, Sherbeny F, Diaby V, Chi H, Ali AA. Application of Machine Learning Algorithms to Predict Uncontrolled Diabetes Using the All of Us Research Program Data. Healthcare (Basel). 2023 Apr 15; 11(8).
Application of Machine Learning Algorithms to Predict Uncontrolled Diabetes Using the All of Us Research Program Data.
Nkemdirim Okere A, Moussa RK, Ali A, Diaby VK
Nkemdirim Okere A, Moussa RK, Ali A, Diaby VK. Development and validation of a tool to predict high-need, high-cost patients hospitalised with ischaemic heart disease. BMJ Open. 2023 09 26; 13(9):e073485.
Development and validation of a tool to predict high-need, high-cost patients hospitalised with ischaemic heart disease.
Biochemistry, Cancer Biology, Neuroscience & Pharmacology
Division of General Internal Medicine and Health Services Research
Ali AA, Kulkarni A, Bhattacharjee S, Diaby V
Ali AA, Kulkarni A, Bhattacharjee S, Diaby V. Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework. Pharmacoeconomics. 2024 Jul; 42(Suppl 2):211-224.
Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework.